Inhibition of proteasome function in rat nigrostriatal dopaminergic neurons as an animal model of Parkinson's disease for studying neuroprotective compounds

被引：0
|
作者：
Lorenc-Koci, Elzbieta [1 ]
Lenda, Tomasz [1 ]
Domin, Helena [2 ]
Jantas, Danuta [3 ]
Smialowska, Maria [2 ]
Zapala, Malgorzata [1 ]
Konieczny, Jolanta [1 ]
机构：
[1] Polish Acad Sci, Dept Neuropsychopharmacol, Inst Pharmacol, PL-31343 Krakow, Poland
[2] Polish Acad Sci, Dept Neurobiol, Inst Pharmacol, PL-31343 Krakow, Poland
[3] Polish Acad Sci, Inst Pharmacol, Dept Expt Neuroendocrinol, PL-31343 Krakow, Poland
来源：
PHARMACOLOGICAL REPORTS | 2010年 / 62卷
关键词：
D O I：
10.1016/S1734-1140(10)71124-5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [1] Inhibition of proteasome function in rat nigrostriatal dopaminergic neurons as an animal model of Parkinson’s disease for studying neuroprotective compounds
    Elżbieta Lorenc-Koci
    Tomasz Lenda
    Helena Domin
    Danuta Jantas
    Maria Śmiałowska
    Małgorzata Zapała
    Jolanta Konieczny
    Pharmacological Reports, 2010, 62 : 33 - 33
  • [2] Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease
    Liu, Li-Xing
    Chen, Wen-Fang
    Xie, Jun-Xia
    Wong, Man-Sau
    NEUROSCIENCE RESEARCH, 2008, 60 (02) : 156 - 161
  • [3] Degeneration of nigrostriatal dopaminergic neurons in an experimental model of the early clinical stage of Parkinson’s disease
    A. A. Kolacheva
    E. A. Kozina
    E. V. Volina
    M. V. Ugryumov
    Neurochemical Journal, 2014, 8 : 184 - 192
  • [4] Degeneration of nigrostriatal dopaminergic neurons in an experimental model of the early clinical stage of Parkinson's disease
    Kolacheva, A. A.
    Kozina, E. A.
    Volina, E. V.
    Ugryumov, M. V.
    NEUROCHEMICAL JOURNAL, 2014, 8 (03) : 184 - 192
  • [5] Colchicine Protects Dopaminergic Neurons in a Rat Model of Parkinson's Disease
    Salama, Mohamed
    Ellaithy, Amr
    Helmy, Basem
    El-Gamal, Mohamed
    Tantawy, Dina
    Mohamed, Mie
    Sheashaa, Hussein
    Sobh, Mohamed
    Arias-Carrion, Oscar
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (07) : 836 - 843
  • [6] Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease
    Anastasia, Agustin
    de Erausquin, Gabriel A.
    Wojnacki, Jose
    Masco, Daniel H.
    JOURNAL OF NEUROCHEMISTRY, 2007, 103 (04) : 1542 - 1552
  • [7] Neuroprotection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease
    de Erausquin, GA
    Anastasia, A
    Reynoso, R
    Morro, HL
    Mascó, DH
    MOVEMENT DISORDERS, 2004, 19 : S226 - S226
  • [8] Study of Yerba Mate (Ilex Paraguariensis) as a Neuroprotective Agent of Dopaminergic Neurons in an Animal Model of Parkinson Disease
    Tribbia, Lilana
    Gomez, Gimena
    Cura, Andrea
    Rivero, Roy
    Bernardi, Alejandra
    Ferrario, Juan
    Baldi-Coronel, Bertha
    Gershanik, Oscar
    Gatto, Emilia
    Taravini, Irene
    NEUROLOGY, 2019, 92 (15)
  • [9] Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson's disease
    Ishibashi, K.
    Kanemaru, K.
    Saito, Y.
    Murayama, S.
    Oda, K.
    Ishiwata, K.
    Mizusawa, H.
    Ishii, K.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 122 (01): : 46 - 51
  • [10] Hyperglycaemia renders nigrostriatal dopaminergic neurons more vulnerable to damage in a mouse model of Parkinson's disease
    Perez-Taboada, I.
    Moratalla, R.
    Vallejo, M.
    DIABETOLOGIA, 2017, 60 : S548 - S548
12345